Twist Bioscience Launches Next-Generation Library Preparation Kits Powered by Proprietary Enzymes
Stocks in this Quantisnow insightHealth Care
Historical context for TWST
Across the 9 sessions after earlier TWST headlines, the stock closed higher 4 times and lower 5 times, with a median move of 4.8% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | TWST | SPY |
|---|---|---|---|
| Feb 3, 2026 | Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4) | -1.0% | -0.8% |
| Feb 2, 2026 | Twist Bioscience Announces Fiscal 2026 First Quarter Financial Results | +14.0% | +0.5% |
| Jan 12, 2026 | Twist Bioscience Announces Preliminary First Quarter Fiscal 2026 Revenue | +7.7% | +0.2% |
| Dec 18, 2025 | Twist Bioscience to Present at J.P. Morgan 2026 Healthcare Conference | -0.7% | +0.8% |
| Dec 4, 2025 | Twist Bioscience Launches New Plasmid Preps to Enable Nucleic Acid Therapeutics Research | +5.3% | +0.1% |
| Nov 14, 2025 | Twist Bioscience Announces Fiscal 2025 Fourth Quarter and Full Year Financial Results | -10.1% | -0.0% |
Quantisnow market dataNASDAQ
TWST
Twist Bioscience Corporation
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Listed since
- 2018
Get push alerts for TWST
Full TWST profile on Quantisnow Follow TWST and get a push notification the moment its next story breaks.